secwatch.observer — SEC 8-K summary
======================================

Issuer:     Drugs Made In America Acquisition Corp. (DMAA)
CIK:        0002028614
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0001213900-25-016702
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SPAC raises $30M via over-allotment; trust now $231.15M
-------------------------------------------------------

- Underwriters exercised over-allotment option in full on Feb 18, 2025; 3M additional units at $10/unit raised $30M.
- Sponsor purchased 30K additional private placement units for $300K, bringing total private units to 430K.
- Total trust account now holds $231.15M from IPO, over-allotment, and private placement proceeds.
- 1,285,714 founder shares are no longer subject to forfeiture due to over-allotment exercise.
- Underwriters received 30K representative shares issued in connection with the over-allotment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2028614/000121390025016702/0001213900-25-016702-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2028614/000121390025016702/ea0231936-8k_drugs.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-016702

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer